참고문헌
- Aggarwal BB, Gupta SC, Kim JH (2012). Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood, 119, 651-65. https://doi.org/10.1182/blood-2011-04-325225
- Bridges JF, Joy SM, Gallego G, et al (2011). Needs for hepatocellular carcinoma control policy in the asia-pacific region. Asian Pac J Cancer Prev, 12, 2585-91.
- Bruce MG, Bruden D, McMahon BJ, et al (2008). Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C. J Viral Hepatitis, 15, 179-87.
- Cheng K, Zhao YJ, Liu L, Wan JJ (2013). Tumor necrosis factor-a 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev, 14, 3275-9. https://doi.org/10.7314/APJCP.2013.14.5.3275
- Choi J, Ou JHJ (2006). Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol, 290, 847-51.
-
Du J, Yuan Z, Zhang C, et al (2010). Role of the TNF-
${\alpha}$ promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone. Leukemia Res, 34, 1453-8. https://doi.org/10.1016/j.leukres.2010.01.011 -
Dwyer BJ, Olynyk JK, Ramm GA, Tirnitz-Parker JE (2014). TWEAK and LT
${\beta}$ Signaling during chronic liver disease. Front Immunol, 5, 39. - El-Serag HB (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 1264-73. https://doi.org/10.1053/j.gastro.2011.12.061
- Forner A, Llovet JM, Bruix J (2012). Hepatocellular carcinoma. Lancet, 379, 1245-55. https://doi.org/10.1016/S0140-6736(11)61347-0
- Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma - current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
-
Goyal A, Kazi SN, Sakhuja P, et al (2004). Association of TNF
${\beta}$ polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol, 72, 60-5. https://doi.org/10.1002/jmv.10533 - Greene FL, Page DL, Fleming ID, et al (2002). American joint committee on cancer staging manual. 6th ed. philadelphia: springer.
- Haybaeck J, Zeller N, Wolf MJ, et al (2009). A lymphotoxindriven pathway to hepatocellular carcinoma. Cancer Cell, 16, 295-308. https://doi.org/10.1016/j.ccr.2009.08.021
- Jemal A, Bray D, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
-
Jeng JE, Tsai JF, Chuang LY, et al (2007). Tumor necrosis factor-
${\alpha}$ 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia, 9, 987-92. https://doi.org/10.1593/neo.07781 -
Jeng JE, Tsai HR, Chuang LY, et al (2009). Independent and additive interactive effects among Tumor necrosis factor-
${\alpha}$ polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine, 88, 349-57. https://doi.org/10.1097/MD.0b013e3181c10477 - Jeng JE, Tsai MF, Tsai HR, et al (2014). Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev, 15, 637-42. https://doi.org/10.7314/APJCP.2014.15.2.637
- Lech-Maranda E, Mlynarski W, Grzybowska-Izydorczyk O (2013). Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia. Genes Chromosomes Cancer, 52, 287-96. https://doi.org/10.1002/gcc.22028
- Li CG, Zhao ZM, Hu MG, Liu R (2012). Predictive role of glutathione-S-transferase gene polymorphisms in risk and prognosis of hepatocellular carcinoma. Asian Pac J Cancer Prev, 13, 3247-52. https://doi.org/10.7314/APJCP.2012.13.7.3247
- Li QW, Lu CR, Ye M, Xiao WH, Liang J (2012). Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 13, 191-4. https://doi.org/10.7314/APJCP.2012.13.1.191
- Liu HZ, Peng J, Peng CY, Yan M, Zheng F (2014). Glutathione s-transferase M1 null genotype and hepatocellular carcinoma susceptibility in China and India: evidence from an updated meta-analysis. Asian Pac J Cancer Prev, 15, 4851-6. https://doi.org/10.7314/APJCP.2014.15.12.4851
- Lu SN, Wang JH, Liu SL, et al (2006). Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer, 107, 2212-22. https://doi.org/10.1002/cncr.22242
-
Luedde T, Schwabe RF (2011). NF-
${\kappa}$ B in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol, 8, 108-18. https://doi.org/10.1038/nrgastro.2010.213 - Messer G, Spengler U, Jung MC, et al (1991). Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med, 173, 209-19. https://doi.org/10.1084/jem.173.1.209
- Menges T, Konig IR, Hossain H, et al (2008). Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor. Crit Care Med, 36, 1456-62. https://doi.org/10.1097/CCM.0B013E318170ABB6
- Nahon P, Zucman-Rossi J (2012). Single nucleotide polymorphisms and risk of hepatocellular carcinoma. J Hepatol, 57, 663-74. https://doi.org/10.1016/j.jhep.2012.02.035
- Okamoto K, Ishida C, Ikebuchi Y, et al (2010). The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Int Med, 49, 887-95. https://doi.org/10.2169/internalmedicine.49.3268
- Pan D, Zeng X, Yu H, et al (2014). Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection. Gene, 544, 32-40. https://doi.org/10.1016/j.gene.2014.04.042
- Rothman KJ (1986). Interactions between causes. in modern epidemiology. Boston: little brown and company, 311-26.
-
Schwabe RF, Brenner DA (2006). Mechanisms of liver injury. I. TNF-
${\alpha}$ -induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol, 290, 583-9. https://doi.org/10.1152/ajpgi.00422.2005 - Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH (2012). Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology, 56, 1567-74. https://doi.org/10.1002/hep.25674
- Su CH, Lin Y, Cai L (2013). Genetic factors, viral infection, other factors and liver cancer: An update on current progress. Asian Pac J Cancer Prev, 14, 4953-60. https://doi.org/10.7314/APJCP.2013.14.9.4953
-
Suneetha PV, Sarin SK, Goyal A, et al (2006). Association between vitamin D receptor, CCR5, TNF-
$\alpha$ and TNF-${\beta}$ gene polymorphisms and HBV infection and severity of liver disease. J Hepatol, 44, 856-63. https://doi.org/10.1016/j.jhep.2006.01.028 - Tian X, Ma P, Sui C, et al (2014). Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk. Tumor Biol, 35, 103-9. https://doi.org/10.1007/s13277-013-1012-8
- Tsai JF, Chang WY, Jeng JE, et al (1993). Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol, 41, 296-300. https://doi.org/10.1002/jmv.1890410407
- Tsai JF, Jeng JE, Chuang LY, et al (2004). Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine, 83, 176-87. https://doi.org/10.1097/01.md.0000126971.80227.a4
- Tsuchiya N, Tokushige K, Yamaguchi N, et al (2004). Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol, 39, 859-66. https://doi.org/10.1007/s00535-004-1402-1
- Wang YD, Zhai WL, Wang HY, Xia XQ (2014). An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 15, 4443-8. https://doi.org/10.7314/APJCP.2014.15.11.4443
- Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev, 14, 6227-31. https://doi.org/10.7314/APJCP.2013.14.11.6227
- Zhang XL, Lu Y, Yang S, et al (2014). An updated metaanalysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 15, 3273-8. https://doi.org/10.7314/APJCP.2014.15.7.3273
피인용 문헌
- Gene Polymorphisms and Serum Levels of Pro- and Anti-Inflammatory Markers in Dengue Viral Infections vol.29, pp.7, 2016, https://doi.org/10.1089/vim.2016.0026